1-methyltryptophan has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Firat, E; Gaedicke, S; Guffart, E; Niedermann, G; Watanabe, T | 1 |
| Gao, S; Hu, Z; Lu, W; Xu, J; Zheng, B | 1 |
| Huang, P; Liu, J; Song, H; Su, Q; Wang, C; Wang, W; Zhang, C; Zhang, J; Zhang, Y | 1 |
3 other study(ies) available for 1-methyltryptophan and B16 Melanoma
| Article | Year |
|---|---|
Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemoradiotherapy; Female; Killer Cells, Natural; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Programmed Cell Death 1 Receptor; Radiation Dose Hypofractionation; Survival Rate; Tryptophan | 2020 |
An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.
Topics: Albumins; Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Compounding; Drug Synergism; Female; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; T-Lymphocytes, Regulatory; Treatment Outcome; Tryptophan; Xenograft Model Antitumor Assays | 2020 |
Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy.
Topics: Animals; Anions; Cancer Vaccines; Cations; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; CpG Islands; Dendritic Cells; Epitopes; Immunotherapy; Lipids; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanostructures; Polymers; Survival Rate; Tryptophan | 2021 |